Overcoming P-Glycoprotein-Mediated Multidrug Resistance in Colorectal Cancer: Potential Reversal Agents Among Herbal Medicines

Evidence-based Complementary and Alternative Medicine - Egypt
doi 10.1155/2018/3412074
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Crown Ethers Reverse P-Glycoprotein-Mediated Multidrug Resistance in Cancer Cells

Scientific Reports
Multidisciplinary
2018English

Overcoming P-Glycoprotein Mediated Drug Resistance With Noscapine Derivatives

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2018English

Carboxymethylcellulose-Based and Docetaxel-Loaded Nanoparticles Circumvent P-Glycoprotein-Mediated Multidrug Resistance

Molecular Pharmaceutics
Drug DiscoveryMolecular MedicinePharmaceutical Science
2014English

Efficient Inhibition of P-Glycoprotein-Mediated Multidrug Resistance With a Monoclonal Antibody.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1992English

Novel Polymer Micelle Mediated Co-Delivery of Doxorubicin and P-Glycoprotein siRNA for Reversal of Multidrug Resistance and Synergistic Tumor Therapy

Scientific Reports
Multidisciplinary
2016English

P‐Glycoprotein, Multidrug Resistance and Protein Kinase C

Oncologist
Cancer ResearchMedicineOncology
1996English

Multidrug-Resistance P-Glycoprotein (MDR1) Secretes Platelet-Activating Factor

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2001English

The Expression and Significance of P-Glycoprotein, Lung Resistance Protein and Multidrug Resistance-Associated Protein in Gastric Cancer

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2009English

HIF-1α Inhibition Reverses Multidrug Resistance in Colon Cancer Cells via Downregulation of MDR1/P-Glycoprotein

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy